Inhibitors of fibril formation and cytotoxicity of β-amyloid peptide composed of KLVFF recognition element and flexible hydrophilic disrupting element

被引:62
作者
Watanabe, K
Nakamura, K
Akikusa, S
Okada, T
Kodaka, M
Konakahara, T
Okuno, H
机构
[1] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan
[2] Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 2788510, Japan
关键词
D O I
10.1006/bbrc.2001.6191
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
beta-Amyloid peptide (Abeta) is the main protein components of neuritic plaques and its neurotoxicity would be exposed by formation of aggregate. The aggregation inhibitors composed of an Abeta recognition element (KLVFF) and a flexible hydrophilic disrupting element (aminoethoxy ethoxy acetate and aspartate) are designed and chemically synthesized. The inhibitory effects are examined by a pigment binding assay using Congo red or thioflavin T. The present compounds suppress the formation of aggregate, and the compound DDX3 is an especially effective inhibitor. In addition, the synthesized compounds efficiently suppress the cytotoxicity of Abeta against IMR-32 neuroblastoma cells in vitro. (C) 2002 Elsevier Science.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 14 条
[1]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[2]  
Esler WP, 1999, METHOD ENZYMOL, V309, P350
[3]   Modified-peptide inhibitors of amyloid β-peptide polymerization [J].
Findeis, MA ;
Musso, GM ;
Arico-Muendel, CC ;
Benjamin, HW ;
Hundal, AM ;
Lee, JJ ;
Chin, J ;
Kelley, M ;
Wakefield, J ;
Hayward, NJ ;
Molineaux, SM .
BIOCHEMISTRY, 1999, 38 (21) :6791-6800
[4]   Inhibition of β-amyloid(40) fibrillogenesis and disassembly of β-amyloid(40) fibrils by short β-amyloid congeners containing N-methyl amino acids at alternate residues [J].
Gordon, DJ ;
Sciarretta, KL ;
Meredith, SC .
BIOCHEMISTRY, 2001, 40 (28) :8237-8245
[5]   2 SIMPLE METHODS FOR QUANTIFYING LOW-AFFINITY DYE SUBSTRATE BINDING [J].
KLUNK, WE ;
PETTEGREW, JW ;
ABRAHAM, DJ .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1989, 37 (08) :1293-1297
[6]   Structure-function relationships for inhibitors of β-amyloid toxicity containing the recognition sequence KLVFF [J].
Lowe, TL ;
Strzelec, A ;
Kiessling, LL ;
Murphy, RM .
BIOCHEMISTRY, 2001, 40 (26) :7882-7889
[7]   Recognition sequence design for peptidyl modulators of β-amyloid aggregation and toxicity [J].
Pallitto, MM ;
Ghanta, J ;
Heinzelman, P ;
Kiessling, LL ;
Murphy, RM .
BIOCHEMISTRY, 1999, 38 (12) :3570-3578
[8]   Translating cell biology into therapeutic advances in Alzheimer's disease [J].
Selkoe, DJ .
NATURE, 1999, 399 (6738) :A23-A31
[9]   Alzheimer's amyloid fibrils: structure and assembly [J].
Serpell, LC .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (01) :16-30
[10]  
SIMMONS LK, 1994, MOL PHARMACOL, V45, P373